(7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal

C63H98N2O9 — CID 170144950

IUPAC(7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal
SMILESC=C/C(=C\N=C(/C)C(C)CC)COC1CCC(C)(CCC(CC=O)CC(=O)C(C)/C=C(\C)C(CC(=O)C(C)CC(C)/C=C/C=C/C=C(\C)C(CC2CCC[C@](O)(C(=O)C(=O)N3CCCCC3)O2)OC)C2CC2)CC1
InChIInChI=1S/C63H98N2O9/c1-12-45(4)50(9)64-42-51(13-2)43-73-54-27-32-62(10,33-28-54)31-26-52(29-36-66)39-57(67)49(8)38-47(6)56(53-24-25-53)41-58(68)48(7)37-44(3)21-16-14-17-22-46(5)59(72-11)40-55-23-20-30-63(71,74-55)60(69)61(70)65-34-18-15-19-35-65/h13-14,16-17,21-22,36,38,42,44-45,48-49,52-56,59,71H,2,12,15,18-20,23-35,37,39-41,43H2,1,3-11H3/b17-14+,21-16+,46-22+,47-38+,51-42+,64-50+/t44?,45?,48?,49?,52?,54?,55?,56?,59?,62?,63-/m1/s1
InChIKeyMXPCDOAIAMRGAK-CZADUTPXSA-N
MW1027.48 g/mol
LogP13.01
Rot. Bonds32

About (7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal

(7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal (PubChem CID 170144950) has the molecular formula C63H98N2O9 and a molecular weight of 1027.48 g/mol. Its IUPAC name is (7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal.

Molecular Properties

Compound Name(7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal
PubChem CID170144950
Molecular FormulaC63H98N2O9
Molecular Weight1027.48 g/mol
Exact Mass1026.73
IUPAC Name(7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal
SMILESC=C/C(=C\N=C(/C)C(C)CC)COC1CCC(C)(CCC(CC=O)CC(=O)C(C)/C=C(\C)C(CC(=O)C(C)CC(C)/C=C/C=C/C=C(\C)C(CC2CCC[C@](O)(C(=O)C(=O)N3CCCCC3)O2)OC)C2CC2)CC1
InChIInChI=1S/C63H98N2O9/c1-12-45(4)50(9)64-42-51(13-2)43-73-54-27-32-62(10,33-28-54)31-26-52(29-36-66)39-57(67)49(8)38-47(6)56(53-24-25-53)41-58(68)48(7)37-44(3)21-16-14-17-22-46(5)59(72-11)40-55-23-20-30-63(71,74-55)60(69)61(70)65-34-18-15-19-35-65/h13-14,16-17,21-22,36,38,42,44-45,48-49,52-56,59,71H,2,12,15,18-20,23-35,37,39-41,43H2,1,3-11H3/b17-14+,21-16+,46-22+,47-38+,51-42+,64-50+/t44?,45?,48?,49?,52?,54?,55?,56?,59?,62?,63-/m1/s1
InChIKeyMXPCDOAIAMRGAK-CZADUTPXSA-N
XLogP13.01
TPSA148.87 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds32
Heavy Atoms74
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001027.48
LogP ≤ 513.01
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze (7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal?
The IUPAC name of (7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal (CID 170144950) is (7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal.
What is the SMILES notation for (7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal?
The canonical SMILES for (7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal is C=C/C(=C\N=C(/C)C(C)CC)COC1CCC(C)(CCC(CC=O)CC(=O)C(C)/C=C(\C)C(CC(=O)C(C)CC(C)/C=C/C=C/C=C(\C)C(CC2CCC[C@](O)(C(=O)C(=O)N3CCCCC3)O2)OC)C2CC2)CC1.
What is the InChIKey of (7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal?
The InChIKey is MXPCDOAIAMRGAK-CZADUTPXSA-N. The full InChI is InChI=1S/C63H98N2O9/c1-12-45(4)50(9)64-42-51(13-2)43-73-54-27-32-62(10,33-28-54)31-26-52(29-36-66)39-57(67)49(8)38-47(6)56(53-24-25-53)41-58(68)48(7)37-44(3)21-16-14-17-22-46(5)59(72-11)40-55-23-20-30-63(71,74-55)60(69)61(70)65-34-18-15-19-35-65/h13-14,16-17,21-22,36,38,42,44-45,48-49,52-56,59,71H,2,12,15,18-20,23-35,37,39-41,43H2,1,3-11H3/b17-14+,21-16+,46-22+,47-38+,51-42+,64-50+/t44?,45?,48?,49?,52?,54?,55?,56?,59?,62?,63-/m1/s1.
What are the key properties of (7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal?
(7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal has a molecular weight of 1027.48 g/mol, XLogP of 13.01, 32 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (7E,15E,17E,19E)-9-cyclopropyl-22-[(6R)-6-hydroxy-6-(2-oxo-2-piperidin-1-ylacetyl)oxan-2-yl]-21-methoxy-6,8,12,14,20-pentamethyl-3-[2-[1-methyl-4-[(2E)-2-[(3-methylpentan-2-ylideneamino)methylidene]but-3-enoxy]cyclohexyl]ethyl]-5,11-dioxodocosa-7,15,17,19-tetraenal is sourced from PubChem (CID 170144950), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).